Secondary analysis of a Kenyan trial of fractional-dose PCV10 or PCV13 in 1342 infants: IgG rose with polysaccharide dose in serotype-specific patterns (quadratic, log-dose or linear), suggesting PCV10/13 could be reformulated.
Secondary analysisn = 1,342
Martinez-de-Albeniz et al. Determining the dose-response relationship for pneumococcal conjugate vaccines: a nested analysis of the fractional dose PCV trial